Sign Up
OverviewAPI
Alcon, a global eye care leader, achieved robust sales and earnings growth in FY 2023, with Q4 sales hitting $2.3 billion and full-year sales at $9.4 billion. The company saw significant increases in Surgical and Vision Care net sales, along with improved operating income and margins. CEO David J. Endicott is optimistic for 2024, emphasizing innovation and long-term shareholder value.

Ask a question